A Study of LY900014 in Participants With Type 1 Diabetes Mellitus

I8B-MC-ITSA -

The purpose of this study is to compare LY900014 with insulin lispro (Humalog) in participants with type 1 diabetes. There are 2 parts to this study. In Part A, the study treatment will be given by injection just under the skin (subcutaneously). In Part B, the study treatment will be given by an insulin pump.

Trial Summary

Age Range
6 - 64 years
Conditions the trial is for
Type 1 Diabetes
What the trial is testing?
Insulin Lispro, LY900014
Could I receive a Placebo?
No
Enrollment Goal
56
Trial Dates
Mar 26, 2018 - Nov 14, 2019
How long will I be in the trial?
Your participation could last about 5 weeks and include up to 4 visits to the study center in each of the 2 parts of the study.
Trial Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.